PDF factsheet

antithrombotics in stable angina for all type of patient, clinical trials results

aspirin versus placebo
SAPAT, 1992	aspirin 75 mg daily versus placebo	patients with stable chronic angina pectoris	double blind Follow-up duration: 50 months Sweden
clopidogrel versus aspirin
ASCET, NCT00222261	clopidogrel 75 mg once daily for two years versus Aspirin 160 mg once daily for two years	patients with documented coronary heart disease and treated with aspirin	open
dipyridamol versus control
Atlanta (Sbar), 1967	dipyridamole 150mg daily versus placebo	patients with angina pectoris	double-blind Follow-up duration: 6 months
Wirecki, 1967	dipyridamole 150mg daily versus placebo	patients with angina pectoris	double blind Follow-up duration: 7 months
Becker, 1967	dipyridamole 225mg daily versus placebo		double-blind Follow-up duration: 5 months
dipyridamol versus placebo
Kinsella, 1962	dipyridamole 37.5 mg and 100mg daily versus placebo		double-blind Follow-up duration: 0.5 months
Leiberman, 1964	dipyridamole 100mg daily versus placebo		double blind Follow-up duration: >3 months
Zion, 1961	Dipyridamole 37.5mg versus placebo	patients with angina pectoris	double-blind Follow-up duration: 0.5 months
Dewar, 1961	Dipyridamole 100mg daily versus placebo	patients with angina pectoris	double-blind Follow-up duration: 0.5 months
Neumann, 1964	dipyridamole 150mg daily versus placebo	elderly with precordial pain	double-blind Follow-up duration: 1.5 months
Foulds, 1960	Dipyridamole 200mg daily versus placebo	patients with angina pectoris	double-blind Follow-up duration: 1 months
Igloe, 1970	Dipyridamole 200mg daily versus placebo	patients with angina pectoris	double blind Follow-up duration: 2-7 months
roxifiban versus placebo
Murphy, 2003	roxifiban 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, or 2.5 mg/day for up to 30 days versus placebo	patients with stable coronary artery disease	double blind Follow-up duration: 30 days
ticlopidine versus placebo
Berglund, 1985	ticlopidine 500 mg daily versus placebo	middle-aged men with stable incapacitating angina pectoris	double blind Follow-up duration: 2m

Options

Group by
in first

in second

Order trials by

Filter

display ongoing trials

Type of trial

Limit to tags

Exclude tags